On Friday, Bluebird bio Inc (NASDAQ: BLUE) opened higher 7.03% from the last session, before settling in for the closing price of $0.95. Price fluctuations for BLUE have ranged from $0.88 to $5.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 10.88% at the time writing. With a float of $189.83 million, this company’s outstanding shares have now reached $192.74 million.
Bluebird bio Inc (BLUE) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Bluebird bio Inc is 1.51%, while institutional ownership is 61.93%. The most recent insider transaction that took place on Mar 04 ’24, was worth 9,311. In this transaction President and CEO of this company sold 6,095 shares at a rate of $1.53, taking the stock ownership to the 279,998 shares. Before that another transaction happened on Mar 04 ’24, when Company’s insider sold 4,573 for $1.53, making the entire transaction worth $6,986. This insider now owns 124,840 shares in total.
Bluebird bio Inc (BLUE) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 15.54 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.88% per share during the next fiscal year.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
Check out the current performance indicators for Bluebird bio Inc (BLUE). In the past quarter, the stock posted a quick ratio of 1.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.74, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -0.88 in one year’s time.
Technical Analysis of Bluebird bio Inc (BLUE)
Bluebird bio Inc (NASDAQ: BLUE) saw its 5-day average volume 7.44 million, a negative change from its year-to-date volume of 8.95 million. As of the previous 9 days, the stock’s Stochastic %D was 14.32%. Additionally, its Average True Range was 0.12.
During the past 100 days, Bluebird bio Inc’s (BLUE) raw stochastic average was set at 3.03%, which indicates a significant decrease from 28.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.20% in the past 14 days, which was lower than the 164.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2626, while its 200-day Moving Average is $2.5085. Nevertheless, the first resistance level for the watch stands at $1.0533 in the near term. At $1.0867, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.1433. If the price goes on to break the first support level at $0.9633, it is likely to go to the next support level at $0.9067. Assuming the price breaks the second support level, the third support level stands at $0.8733.
Bluebird bio Inc (NASDAQ: BLUE) Key Stats
There are currently 109,336K shares outstanding in the company with a market cap of 196.59 million. Presently, the company’s annual sales total 3,600 K according to its annual income of -266,580 K. Last quarter, the company’s sales amounted to 12,390 K and its income totaled -71,730 K.
